ZOMDF
Zomedica Corp.
Price Chart
Latest Quote
$0.13
Current Price| Previous Close | $0.13 |
| Open | $0.12 |
| Day High | $0.14 |
| Day Low | $0.12 |
| Volume | 330,897 |
Stock Information
| Shares Outstanding | 979.95M |
| Total Debt | $2.35M |
| Cash Equivalents | $53.12M |
| Revenue | $29.45M |
| Net Income | $-84.52M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $127.69M |
| EPS (TTM) | $-0.09 |
| Exchange | OQB |
đ Custom Metrics & Score
Score: 22/42| Debt to Equity | 0.01 |
| Debt to Earnings | 0.10 |
| Current Ratio | 8.76 |
| Quick Ratio | 7.98 |
| Avg Revenue Growth | 140.04% |
| Profit Margin | -172.19% |
| Return on Equity | -24.01% |
| Avg FCF Growth | 26.38% |
| FCF Yield | -23.83% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $0.13 | 330,897 |
| 2026-01-30 | $0.13 | 853,000 |
| 2026-01-29 | $0.13 | 1,226,300 |
| 2026-01-28 | $0.14 | 716,900 |
| 2026-01-27 | $0.14 | 888,700 |
| 2026-01-26 | $0.14 | 1,023,400 |
| 2026-01-23 | $0.13 | 1,189,000 |
| 2026-01-22 | $0.14 | 863,700 |
| 2026-01-21 | $0.12 | 708,600 |
| 2026-01-20 | $0.12 | 1,909,900 |
| 2026-01-16 | $0.13 | 3,498,500 |
| 2026-01-15 | $0.15 | 1,375,500 |
| 2026-01-14 | $0.15 | 1,724,300 |
| 2026-01-13 | $0.15 | 2,581,200 |
| 2026-01-12 | $0.15 | 3,313,900 |
| 2026-01-09 | $0.14 | 5,034,100 |
| 2026-01-08 | $0.13 | 3,077,300 |
| 2026-01-07 | $0.12 | 1,484,000 |
| 2026-01-06 | $0.12 | 2,542,500 |
| 2026-01-05 | $0.11 | 2,815,000 |
About Zomedica Corp.
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.
đ° Latest News
No news articles available at the moment. Check back later for updates on ZOMDF.
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $8,198,000 | $7,868,000 | $5,462,000 | $1,079,000 |
| Cost Of Revenue | $8,198,000 | $7,868,000 | $5,462,000 | $1,079,000 |
| Total Revenue | $27,285,000 | $25,186,000 | $18,930,000 | $4,133,000 |
| Operating Revenue | $27,285,000 | $25,186,000 | $18,930,000 | $4,133,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $0 | $175,000 | $1,000 | $6,000 |
| Total Expenses | $62,314,000 | $56,778,000 | $40,853,000 | $25,507,000 |
| Other Income Expense | $-16,476,000 | $-9,551,000 | $-158,000 | $306,000 |
| Other Non Operating Income Expenses | $10,000 | $2,080,000 | $-7,000 | $52,000 |
| Net Non Operating Interest Income Expense | $3,966,000 | $5,283,000 | $2,700,000 | $351,000 |
| Interest Expense Non Operating | $0 | $175,000 | $1,000 | $6,000 |
| Operating Expense | $54,116,000 | $48,910,000 | $35,391,000 | $24,428,000 |
| Selling And Marketing Expense | $17,192,000 | $14,137,000 | $9,879,000 | - |
| General And Administrative Expense | $29,656,000 | $29,029,000 | $22,934,000 | - |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-46,982,000 | $-34,529,000 | $-17,015,000 | $-18,384,000 |
| Net Interest Income | $3,966,000 | $5,283,000 | $2,700,000 | $351,000 |
| Interest Income | $3,966,000 | $5,458,000 | $2,701,000 | $357,000 |
| Normalized Income | $-30,689,161 | $-23,329,703 | $-16,882,434 | $-18,609,396 |
| Net Income From Continuing And Discontinued Operation | $-46,982,000 | $-34,529,000 | $-17,015,000 | $-18,384,000 |
| Total Operating Income As Reported | $-51,053,000 | $-43,275,000 | $-21,923,000 | $-21,374,000 |
| Net Income Common Stockholders | $-46,982,000 | $-34,529,000 | $-17,015,000 | $-50,423,000 |
| Net Income | $-46,982,000 | $-34,529,000 | $-17,015,000 | $-18,384,000 |
| Net Income Including Noncontrolling Interests | $-46,982,000 | $-34,529,000 | $-17,015,000 | $-18,384,000 |
| Net Income Continuous Operations | $-46,982,000 | $-34,529,000 | $-17,015,000 | $-18,384,000 |
| Pretax Income | $-47,539,000 | $-35,860,000 | $-19,381,000 | $-20,717,000 |
| Special Income Charges | $-16,234,000 | $-11,659,000 | $1,000 | $284,000 |
| Interest Income Non Operating | $3,966,000 | $5,458,000 | $2,701,000 | $357,000 |
| Operating Income | $-35,029,000 | $-31,592,000 | $-21,923,000 | $-21,374,000 |
| Gross Profit | $19,087,000 | $17,318,000 | $13,468,000 | $3,054,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $-0.05 | $-0.04 | $-0.02 | $-0.05 |
| Basic EPS | $-0.05 | $-0.04 | $-0.02 | $-0.05 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $-193,161 | $-431,703 | $-18,434 | $28,604 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-23,067,000 | $-17,756,000 | $-15,187,000 | $-19,826,000 |
| Total Unusual Items | $-16,486,000 | $-11,631,000 | $-151,000 | $254,000 |
| Total Unusual Items Excluding Goodwill | $-16,486,000 | $-11,631,000 | $-151,000 | $254,000 |
| Reconciled Depreciation | $7,986,000 | $6,298,000 | $4,042,000 | $1,139,000 |
| EBITDA (Bullshit earnings) | $-39,553,000 | $-29,387,000 | $-15,338,000 | $-19,572,000 |
| EBIT | $-47,539,000 | $-35,685,000 | $-19,380,000 | $-20,711,000 |
| Diluted Average Shares | $979,949,668 | $979,949,668 | $979,949,668 | $956,533,761 |
| Basic Average Shares | $979,949,668 | $979,949,668 | $979,949,668 | $956,533,761 |
| Diluted NI Availto Com Stockholders | $-46,982,000 | $-34,529,000 | $-17,015,000 | $-50,423,000 |
| Tax Provision | $-557,000 | $-1,331,000 | $-2,366,000 | $-2,333,000 |
| Gain On Sale Of Ppe | $-210,000 | $24,000 | $1,000 | $-249,000 |
| Write Off | $16,024,000 | $11,683,000 | $0 | - |
| Gain On Sale Of Security | $-252,000 | $28,000 | $-152,000 | $-30,000 |
| Research And Development | $7,268,000 | $5,744,000 | $2,578,000 | $1,673,000 |
| Selling General And Administration | $46,848,000 | $43,166,000 | $32,813,000 | $22,755,000 |
| Other Gand A | $29,656,000 | $29,029,000 | $22,934,000 | - |
| Otherunder Preferred Stock Dividend | - | - | $0 | $32,039,000 |
| Other Special Charges | - | - | - | $-533,000 |
| Provision For Doubtful Accounts | - | - | - | $6,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $97,570,000 | $123,073,000 | $161,614,000 | $194,424,000 |
| Total Assets | $207,360,000 | $253,197,000 | $279,610,000 | $280,400,000 |
| Total Non Current Assets | $125,587,000 | $153,315,000 | $156,109,000 | $79,993,000 |
| Other Non Current Assets | $1,100,000 | $822,000 | $265,000 | $265,000 |
| Non Current Prepaid Assets | $193,000 | $250,000 | $188,000 | $394,000 |
| Investmentin Financial Assets | $0 | $10,005,000 | $40,712,000 | $0 |
| Goodwill And Other Intangible Assets | $98,094,000 | $116,944,000 | $105,778,000 | $76,464,000 |
| Other Intangible Assets | $52,538,000 | $55,364,000 | $41,799,000 | $33,176,000 |
| Current Assets | $81,773,000 | $99,882,000 | $123,501,000 | $200,407,000 |
| Prepaid Assets | $2,291,000 | $2,064,000 | $3,799,000 | $1,842,000 |
| Inventory | $5,058,000 | $5,123,000 | $2,746,000 | $2,848,000 |
| Receivables | $3,071,000 | $2,198,000 | $1,864,000 | $765,000 |
| Other Receivables | $648,000 | $1,001,000 | $1,268,000 | $450,000 |
| Accounts Receivable | $2,423,000 | $1,197,000 | $596,000 | $315,000 |
| Allowance For Doubtful Accounts Receivable | $-371 | $-103 | $-71 | $-34,000 |
| Gross Accounts Receivable | $2,423,371 | $1,197,103 | $596,071 | $349,418 |
| Cash Cash Equivalents And Short Term Investments | $71,353,000 | $90,497,000 | $115,092,000 | $194,952,000 |
| Cash And Cash Equivalents | $7,021,000 | $12,952,000 | $27,399,000 | $194,952,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Debt | $1,814,000 | $2,730,000 | $1,738,000 | $1,379,000 |
| Long Term Debt And Capital Lease Obligation | $1,291,000 | $1,814,000 | $1,097,000 | $964,000 |
| Current Debt And Capital Lease Obligation | $523,000 | $916,000 | $641,000 | $415,000 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $11,696,000 | $13,180,000 | $12,218,000 | $9,512,000 |
| Total Non Current Liabilities Net Minority Interest | $2,365,000 | $4,148,000 | $4,407,000 | $5,172,000 |
| Other Non Current Liabilities | $399,000 | $944,000 | $1,883,000 | $359,000 |
| Non Current Deferred Liabilities | $675,000 | $1,390,000 | $1,427,000 | $3,849,000 |
| Non Current Deferred Taxes Liabilities | $456,000 | $1,138,000 | $1,245,000 | $3,709,000 |
| Current Liabilities | $9,331,000 | $9,032,000 | $7,811,000 | $4,340,000 |
| Other Current Liabilities | $336,000 | $362,000 | $78,000 | $262,000 |
| Current Deferred Liabilities | $331,000 | $276,000 | $207,000 | $198,000 |
| Payables And Accrued Expenses | $3,584,000 | $3,347,000 | $6,885,000 | $3,465,000 |
| Payables | $3,049,000 | $3,202,000 | $6,885,000 | $3,465,000 |
| Total Tax Payable | $1,120,000 | $1,134,000 | $187,000 | $240,000 |
| Income Tax Payable | $117,000 | $65,000 | $187,000 | $240,000 |
| Accounts Payable | $1,929,000 | $2,068,000 | $6,698,000 | $3,225,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $195,664,000 | $240,017,000 | $267,392,000 | $270,888,000 |
| Total Equity Gross Minority Interest | $195,664,000 | $240,017,000 | $267,392,000 | $270,888,000 |
| Stockholders Equity | $195,664,000 | $240,017,000 | $267,392,000 | $270,888,000 |
| Gains Losses Not Affecting Retained Earnings | $88,000 | $48,000 | $-843,000 | $2,000 |
| Other Equity Adjustments | $88,000 | $48,000 | $-843,000 | $2,000 |
| Retained Earnings | $-217,915,000 | $-170,933,000 | $-136,404,000 | $-119,389,000 |
| Preferred Securities Outside Stock Equity | - | - | - | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $979,949,668 | $979,949,668 | $979,949,668 | $979,899,668 |
| Share Issued | $979,949,668 | $979,949,668 | $979,949,668 | $979,899,668 |
| Tangible Book Value | $97,570,000 | $123,073,000 | $161,614,000 | $194,424,000 |
| Invested Capital | $195,664,000 | $240,017,000 | $267,392,000 | $270,888,000 |
| Working Capital | $72,442,000 | $90,850,000 | $115,690,000 | $196,067,000 |
| Capital Lease Obligations | $1,814,000 | $2,730,000 | $1,738,000 | $1,379,000 |
| Total Capitalization | $195,664,000 | $240,017,000 | $267,392,000 | $270,888,000 |
| Additional Paid In Capital | $32,518,000 | $29,929,000 | $23,666,000 | $9,313,000 |
| Capital Stock | $380,973,000 | $380,973,000 | $380,973,000 | $380,962,000 |
| Common Stock | $380,973,000 | $380,973,000 | $380,973,000 | $380,962,000 |
| Non Current Deferred Revenue | $219,000 | $252,000 | $182,000 | $140,000 |
| Long Term Capital Lease Obligation | $1,291,000 | $1,814,000 | $1,097,000 | $964,000 |
| Current Deferred Revenue | $331,000 | $276,000 | $207,000 | $198,000 |
| Current Capital Lease Obligation | $523,000 | $916,000 | $641,000 | $415,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $4,557,000 | $4,131,000 | - | - |
| Current Accrued Expenses | $535,000 | $145,000 | - | - |
| Investments And Advances | $0 | $10,005,000 | $40,712,000 | $0 |
| Goodwill | $45,556,000 | $61,580,000 | $63,979,000 | $43,288,000 |
| Net PPE | $26,200,000 | $25,294,000 | $9,166,000 | $2,870,000 |
| Accumulated Depreciation | $-3,416,000 | $-2,045,000 | $-1,277,000 | $-884,000 |
| Gross PPE | $29,616,000 | $27,339,000 | $10,443,000 | $3,754,000 |
| Leases | $3,088,000 | $1,953,000 | $1,239,000 | $287,000 |
| Construction In Progress | $7,889,000 | $12,481,000 | $692,000 | $420,000 |
| Other Properties | $2,468,000 | $3,539,000 | $1,914,000 | $1,545,000 |
| Machinery Furniture Equipment | $16,171,000 | $9,366,000 | $6,598,000 | $1,502,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-26,000 | $-49,000 | $-40,000 | $-30,000 |
| Finished Goods | $539,000 | $397,000 | $182,000 | $140,000 |
| Raw Materials | $4,545,000 | $4,775,000 | $2,604,000 | $2,738,000 |
| Other Short Term Investments | $64,332,000 | $77,545,000 | $87,693,000 | $0 |
| Available For Sale Securities | - | $10,005,000 | $40,712,000 | - |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-30,423,000 | $-31,464,000 | $-12,696,000 | $-14,802,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-23,630,000 | $-15,975,000 | $-11,670,000 | $-14,276,000 |
| Cash Flow From Continuing Operating Activities | $-23,630,000 | $-15,975,000 | $-11,670,000 | $-14,276,000 |
| Operating Gains Losses | $369,000 | $-24,000 | $-1,000 | $-285,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-6,793,000 | $-15,489,000 | $-1,026,000 | $-526,000 |
| Investing Cash Flow | $17,854,000 | $1,577,000 | $-155,880,000 | $-71,925,000 |
| Cash Flow From Continuing Investing Activities | $17,854,000 | $1,577,000 | $-155,880,000 | $-71,925,000 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Financing Cash Flow | $-70,000 | $0 | $8,000 | $219,159,000 |
| Cash Flow From Continuing Financing Activities | $-70,000 | $0 | $8,000 | $219,159,000 |
| Net Other Financing Charges | $-70,000 | - | - | $-14,270,000 |
| Issuance Of Capital Stock | - | - | $0 | $199,525,000 |
| Net Common Stock Issuance | - | - | $0 | $199,525,000 |
| Common Stock Issuance | - | - | $0 | $199,525,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| End Cash Position | $7,021,000 | $12,952,000 | $27,399,000 | $194,952,000 |
| Beginning Cash Position | $12,952,000 | $27,399,000 | $194,952,000 | $61,992,000 |
| Effect Of Exchange Rate Changes | $-85,000 | $-49,000 | $-11,000 | $2,000 |
| Changes In Cash | $-5,846,000 | $-14,398,000 | $-167,542,000 | $132,958,000 |
| Net Investment Purchase And Sale | $25,084,000 | $41,025,000 | $-130,550,000 | $0 |
| Sale Of Investment | $25,084,000 | $42,775,000 | - | - |
| Purchase Of Investment | $0 | $-1,750,000 | $-130,550,000 | $0 |
| Net Business Purchase And Sale | $-437,000 | $-23,959,000 | $-24,304,000 | $-71,399,000 |
| Purchase Of Business | $-437,000 | $-23,959,000 | $-24,304,000 | $-71,399,000 |
| Net Intangibles Purchase And Sale | $-1,581,000 | $-4,150,000 | $-239,000 | $-379,000 |
| Purchase Of Intangibles | $-1,581,000 | $-4,150,000 | $-239,000 | $-379,000 |
| Net PPE Purchase And Sale | $-5,212,000 | $-11,339,000 | $-787,000 | $-147,000 |
| Purchase Of PPE | $-5,212,000 | $-11,339,000 | $-787,000 | $-147,000 |
| Change In Working Capital | $-1,071,000 | $19,000 | $-3,163,000 | $-3,876,000 |
| Change In Other Working Capital | $22,000 | $320,000 | $235,000 | $-2,522,000 |
| Change In Other Current Liabilities | $-545,000 | $-761,000 | $-709,000 | $154,000 |
| Change In Payables And Accrued Expense | $459,000 | $289,000 | $3,401,000 | $1,608,000 |
| Change In Accrued Expense | $606,000 | $30,000 | - | - |
| Change In Payable | $-147,000 | $259,000 | $3,401,000 | $1,608,000 |
| Change In Account Payable | $-200,000 | $384,000 | $3,454,000 | $1,412,000 |
| Change In Tax Payable | $53,000 | $-125,000 | $-53,000 | $196,000 |
| Change In Income Tax Payable | $53,000 | $-125,000 | $-53,000 | $196,000 |
| Change In Prepaid Assets | $-178,000 | $1,499,000 | $-1,465,000 | $-130,000 |
| Change In Inventory | $-205,000 | $-1,059,000 | $-4,008,000 | $-2,774,000 |
| Change In Receivables | $-624,000 | $-269,000 | $-617,000 | $-212,000 |
| Changes In Account Receivables | $-1,227,000 | $-617,000 | $-283,000 | $-47,000 |
| Other Non Cash Items | $-61,000 | $-1,987,000 | $16,000 | $38,000 |
| Stock Based Compensation | $2,778,000 | $6,263,000 | $7,891,000 | $7,092,000 |
| Asset Impairment Charge | $16,024,000 | $11,683,000 | $0 | - |
| Amortization Of Securities | $-1,991,000 | $-2,209,000 | $-900,000 | $0 |
| Deferred Tax | $-682,000 | $-1,489,000 | $-2,540,000 | - |
| Deferred Income Tax | $-682,000 | $-1,489,000 | $-2,540,000 | - |
| Depreciation Amortization Depletion | $7,986,000 | $6,298,000 | $4,042,000 | $1,139,000 |
| Depreciation And Amortization | $7,986,000 | $6,298,000 | $4,042,000 | $1,139,000 |
| Amortization Cash Flow | $6,441,000 | $5,468,000 | $3,616,000 | $874,000 |
| Amortization Of Intangibles | $6,441,000 | $5,468,000 | $3,616,000 | $874,000 |
| Depreciation | $1,545,000 | $830,000 | $426,000 | $265,000 |
| Earnings Losses From Equity Investments | $159,000 | $0 | - | - |
| Gain Loss On Sale Of PPE | $210,000 | $-24,000 | $-1,000 | $249,000 |
| Net Income From Continuing Operations | $-46,982,000 | $-34,529,000 | $-17,015,000 | $-18,384,000 |
| Proceeds From Stock Option Exercised | - | $0 | $8,000 | $33,904,000 |
| Interest Paid Supplemental Data | - | - | - | $0 |
| Sale Of PPE | - | - | - | $225 |